Abnormal initiation and control of voluntary movements are among the principal 19 manifestations of Parkinson's disease (PD). However, the processes underlying these 20 abnormalities and their potential remediation by dopamine treatment remain poorly 21 understood. Normally, movements depend on the integration of sensory information 22
with the predicted consequences of action. This integration leads to a suppression in 23 the intensity of predicted sensations, and increases the relative salience of unexpected 24 stimuli to facilitate the control of movements. We examined this integration process 25 and its relation to dopamine in PD, by measuring sensorimotor attenuation -the 26 reduction in the perceived intensity of predicted sensations from self-generated versus 27 external actions. Patients with idiopathic PD (n=18) and population-derived controls 28 (n=175) matched a set of target forces applied to their left index finger by a torque 29 motor. To match the force, participants either pressed with their right index finger 30 ('Direct' condition) or used a linear potentiometer that controlled a motor ('Slider' 31 condition). We found that despite changes in sensitivity to different forces, overall 32 sensory attenuation did not differ between medicated PD patients and controls. 33 Importantly, the degree of attenuation was negatively related to PD motor severity but 34 positively related to individual patient dopamine dose, as measured by levodopa dose 35 equivalency. The results suggest that dopamine could regulate the integration of 36 sensorimotor prediction with sensory information to facilitate the control of voluntary 37 movements. 38
INTRODUCTION 39
A key manifestation of Parkinson's disease (PD) is bradykinesia -that is, patients 40 have marked difficulties in planning, initiating and executing voluntary movements 41 (Jankovic, 2008) . This principal abnormality in motor control has been shown to 42 correlate well with dopamine disruption in patients (Vingerhoets et al, 1997) , 43 however, the exact mechanism remains poorly understood. Normal motor control 44 depends on the integration of peripheral sensory information with predictions arising 45 from internal models of action. The integration is dependent on the relative 46 'precision' of sensory information and predictions (Franklin and Wolpert, 2011) , such 47 that in an uncertain environment, for example, people's movements rely more on 48 prediction (Körding and Wolpert, 2004 ). Dopamine has been suggested to play a 49 central role in regulating the precision of sensory information relative to predictions 50 (Friston et al, 2012) . Striatal dopamine deficit, which is a hallmark pathological 51 feature in PD, is therefore expected to lead to reduced reliance on sensory information 52 (Vilares and Kording, 2017; Wolpe et al, 2015) and reduced sensory sensitivity 53 (Konczak et al, 2012) . However, PD also substantially increases the relative reliance 54 on sensory information; for example, PD patients are more dependent on sensory cues 55 for initiating movements (Morris et al, 1996) , and the withdrawal of visual feedback 56 impairs patients more than healthy individuals in terms of both movement speed and 57 accuracy (Klockgether and Dichgans, 1994) . Here, we examine the integration 58 between sensory signals and predictions in PD, through sensorimotor attenuation. 59 60 Sensorimotor attenuation is the reduction in the perceived intensity of stimuli 61 generated by one's actions, compared to externally generated stimuli. It reflects the 62 suppression of predicted sensory consequences from perception (Blakemore et al, 63 Participants 94 Eighteen patients (12 men; aged 48-81 years, mean: 67; SD: 10) were recruited from 95 the John van Geest Centre for Brain Repair, Parkinson's disease research clinic. 96
Patients met clinical diagnostic criteria of idiopathic PD, according to the UK PD 97 brain bank criteria (Hughes et al, 1992) , and were in the mild to moderate stages of 98 disease [Hoehn and Yahr stages 1 to 3] (Hoehn and Yahr, 1967 (Fahn and Elton, 1987) . 109
Cognition was assessed with the Mini-Mental State Examination (Folstein et al, 1975) 110 and Addenbrooke's Cognitive Examination Revised (Mioshi et al, 2006) , excluding 111 patients with ACE-R score below 84/100 (Reyes et al, 2009 ). Patients were tested in 112 the morning after taking their medication as normal. The time interval between 113 levodopa self-administration and testing varied between one and three hours, such 114 that all patients were in a relative 'on' state at the time they were assessed. Levodopa 115 dose equivalency (LDE) was computed according to Tomlinson et al. (2010) . Clinical 116 data were collected and scored independently and blind to the behavioural results. 117 7 118 Force matching task procedures and analyses 119 On each trial of the Force Matching Task (Shergill et al, 2003) , a lever attached to a 120 torque motor applied the target force for 2.5 s to the left index finger (Fig. 1) . The 121 target force was pseudo-randomly selected from the set: 1.0, 1.5, 2.0 and 2.5 Newton 122 (N): each target force was presented once within a cycle of four trials. At the end of 123 the presentation period, the force was removed, and participants used their right index 124 finger to match the force they had just sensed on their left finger (matching period 4.5 125 sec long). Premature (response during the presentation period) or late (> 1 s) 126 responses led to a warning "too fast" or "too slow" on the computer screen, and the 127 trial was repeated. Because PD patients have altered force output [e.g. increased force 128 irregularities and time to peak (Stelmach et al, 1989) ], the matched force was 129 calculated as the mean force measured within a 500 ms time window that was 130 selected on a trial-by-trial basis. A sliding window was used to identify the 500 ms 131 interval that had the minimum force variability. This procedure was implemented in 132 both patient and control data. Table 1 . Patients (n=18) and controls 164 (n=175) were not different in terms of age (Mann-Whitney test; Z = 0.92, p = 0.36) 165 and gender (χ 2 = 1.64, p = 0.2). 166 167
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168
In order to calculate the matched force for each participant and trial, we calculated the 169 mean force during a 500 ms interval that had the minimum force variability, found 170 with a sliding window. There was no significant difference between initiation times of 171 force matching in patients and controls (Mann-Whitney test; Z = -1.58, p = 0.11). 172 Importantly the mean time at which patients and controls stabilised the force after 173 initiation was not different (2.67 s versus 2.73 s in patients and controls; Whitney test; Z = -0.37, p = 0.71). In the Slider condition, initiation times of force 175 matching were similar across groups (Z = 1.39, p = 0.16), and patients stabilised the 176 forces slower than controls (2.61 s versus 2.36 s in patients and controls; Whitney test; Z = 2.78, p < 0.01). The distributions of calculated mean 178 overcompensation (mean difference between matched and target force) for both 179 conditions in patients were not different from normal distribution (one-sample 180 Kolmogorov-Smirnov test; Direct: D = 0.228, p = 0.26, Slider: D = 0.137, p = 0.845). 181 182 All patients showed overall sensory attenuation, as indicated by a positive mean 183 overcompensation in the Direct condition ( Fig. 2A ). Mean Direct force 184 overcompensation was greater than zero (t 17 = 6.94, p < 0.001), at 1.51 N (SD = 0.92 185 N). Patients were more accurate when matching the force in the Slider condition ( Fig.  186 10 2A), with smaller force overcompensation than in the Direct condition (t 17 = -5.93, p 187 < 0.001). Mean Slider force overcompensation was -0.01 N (SD = 0.36 N), and was 188 not significantly different from zero (t 17 = -0.12, p = 0.91). These results confirm that 189 sensory attenuation is as robust in PD patients as in the general population (Wolpe et 190 al, 2016) . patients, we conducted several control analyses to verify the patients' abilities to 222 match the forces in the Direct condition. Compared to controls, patients showed 223 increased within-trial variability in the forces they applied (Mann-Whitney test; Z = 224 2.72, p < 0.01), consistent with previous findings in PD (Stelmach et al, 1989) . This is 225 likely to arise from reduced force sensitivity due to increased sensory variability 226 (Konczak et al, 2012) , which, importantly, is not expected to introduce a systematic 227 bias given the nature of the force matching task (see Discussion). However, increased 228 within-trial force variability could also arise from the patients 'overshooting' and then 229 slowly adjusting the force; an impaired ability to decide what force to apply; and/or 230 from difficulties maintaining a steady force due to fatigue. 231
232
To explore the possibility of a systematic bias in the matching procedure, we 233 performed additional analyses. First, for each trial, within the analysed time window, 234
we fit a linear regression model of matched force against time. There was no linear 235 trend in the matched force (regression slope not significantly different from zero; t 17 = 236 12 -0.96, p = 0.35), similar to controls (Mann-Whitney test; Z = 0.53, p = 0.53). 237
Moreover, there was no consistent relationship between this linear trend and the 238 magnitude of the force applied by each patient (mean Pearson correlation coefficient 239 not different from zero in patients; t 17 = -1.41, p = 0.18), which was again similar to 240 controls (Mann-Whitney; Z = 0.15, p = 0.25). These results suggest it is unlikely that 241 patients fatigued in the force they applied. Further, although not significantly different 242 from controls, the slope in the Direct condition was overall smaller in patients relative 243 to controls (see Figure 2B ). This raises the possibility that patients were more limited 244 in their ability to match larger forces. However, a closer look at the Direct slope 245 demonstrated it was not significantly different from a veridical slope of one 246 (Wilcoxon signed-rank test; Z = -1.76, p = 0.08). To further explore patient 247 performance in matching larger forces, we computed the Pearson coefficient of the 248 correlation between the magnitude of matched forces and within-trial SD for each 249 trial and for each subject. There was a consistently positive relationship between the 250 matched force and within-trial SD in patients (mean Pearson correlation coefficient 251 significantly greater than zero across patients; t 17 = 8.09, p < 0.001), consistent with 252 the well-known association between generated force variability and force level (Jones 253 et al, 2002) . Importantly, however, this association did not differ from controls 254 (Mann-Whitney test; Z = -1.21, p = 0.23). Taken together, these control analyses 255 suggest that PD did not alter the matching procedure itself. Nevertheless, we 256 accounted for group differences in matching procedure (within-trial variability and R 2 257 of the matched against target force) in the next analysis. The principal result of our study is that sensorimotor attenuation is positively related 290 to dopamine doses in PD patients, whereas PD severity is related to reduced 291 attenuation. These results can be interpreted in the context of optimal control theory, 292 in which voluntary actions rely on the integration of sensory feedback with 293 predictions of the consequences of one's actions . The 294 integration is precision-dependent, such that low-precision signals are down-weighted 295 relative to high-precision signals. For example, this means that when performing a 296 task in a dark or foggy setting, the precision of sensory feedback is expected to be 297 low, and the sensorimotor system therefore relies more strongly on prior predictions 298 when performing an action (Körding and Wolpert, 2004) . Sensory attenuation is 299 thought to reflect the precision of predictive signals (Bays et al, 2006) , relative to the 300 precision of sensory feedback (Brown et al, 2013; Wolpe et al, 2016) . Our finding 301 that PD motor severity is associated with reduced attenuation would therefore suggest 302 that the precision of predictive signals may be compromised in PD (Macerollo et al, 303 2016 ). This may underlie the changes of sensorimotor integration in PD (Abbruzzese 304 and Berardelli, 2003) and the dependence of patients on sensory cues, e.g. for the 305 initiation and maintenance of their movement (Klockgether and Dichgans, 1994) . 306
307
Although the severity of parkinsonism and doses of dopamine replacement therapy 308 were positively correlated, dopamine was associated with an opposite effect, namely 309 increased attenuation. These results support the hypothesis that dopamine alleviates 310 disorders of movement in PD by restoring the precision and hence the typical reliance 311 on sensorimotor predictions (Macerollo et al, 2016) , at the expense of down-312 weighting the sensorium. This is further supported by the finding that an increase in 313 16 dopamine dose was related to reduced force sensitivity in the Slider condition. These 314 results are further consistent with the exaggeration of age-related sensory deficits in 315 medicated PD patients (Konczak et al, 2012) neurophysiological attenuation of these early components following a voluntary 360 movement is absent in PD patients 'off' medication, and restored by dopamine 361 treatment (Macerollo et al, 2016) . This reduced neurophysiological attenuation of the 362 18 early components of sensory evoked potential has been attributed to a failure in 363 sensory 'gating' in PD (Macerollo et al, 2016) , resulting from abnormal precision of 364 sensory afferents (Brown et al, 2013) . 365
366
The neurophysiological gating of sensory afferent signals before and during 367 movement has been proposed to be required for the initiation processes of voluntary 368 movements (Barker, 1988; Brown et al, 2013) . This theoretical account suggests that 369 a relative reduction in the precision of sensory signals, leading to sensory attenuation, 370 enables high-level predictions to drive normal movement through hierarchical 371 networks in the central nervous system (Brown et al, 2013) . In PD, deficient precision 372 of predictions would be overwhelmed by sensory evidence for a lack of movement, 373 resulting in bradykinesia (Brown et al, 2013) . Although the neurophysiological 374 attenuation of early components of sensory evoked potentials, shown to be impaired 375 in PD and remediated with dopamine, may not directly underlie the behavioural 376 phenomenon of attenuation (Palmer et al, 2016) , our behavioural results are consistent 377 with these previous studies. Our findings that PD motor severity is associated with 378 reduced attenuation while dopamine dose is related to increased attenuation, support 379 the hypothesis that bradykinesia in Parkinson's disease could be considered in terms 380 of pathological imprecision of sensorimotor prediction, which are alleviated by 381 dopamine treatment. 382
383
Our results have interpretative limitations that should be considered. Firstly, we opted 384 for the force matching task, as it is a simple, highly intuitive and robust task (Wolpe 385 et al, 2016) . Importantly, in a matching task any absolute bias is factored out and 386 therefore sensory deficits, which are common in PD (Konczak et al, 2012) , can 387 19 increase performance variability, as observed in our study, but are unlikely to 388 introduce a systematic bias (e.g. with a force of 'X' N sensed as X/2 N, patients 389 would still have to match X N to experience the same X/2 N intensity). However, the 390 task does have its limitations and preliminary testing showed that the it is not easily 391 performed by PD patients 'off' medication, mainly because of tremor and akinesia in 392 light of the timed, dexterous movements required for matching the forces. Patients 393 were thus tested in an 'on' state, to avoid the confound of severe performance 394 problems, and we draw inferences from the between-subject variability in disease 395 severity and dopamine doses. We therefore cannot draw causal inferences on the 396 effect of dopamine in patients. Secondly, the reduced slope in the Direct and Slider 397 conditions suggests that reduced sensory sensitivity may have dominated patient 398 behaviour in the task (Konczak et al, 2012) . Importantly, differences in patient force 399 sensitivities were accounted for in main regression analyses, together with other 400 potential confounders, suggesting that reduced force sensitivity was not a sufficient 401 explanation for the significant associations between attenuation, disease severity and 402 dopamine dose. 403
404
In conclusion, our study suggests that dopamine is related to an increase in sensory 405 attenuation in PD, suggesting that dopamine increases the precision of sensorimotor 406 predictions. The results support the hypothesis that bradykinesia in movement 407 disorders like PD can, in part, be considered in terms of pathological (im)precision of 408 sensorimotor predictions (Brown et al, 2013) , which can be modulated by dopamine 409 (Macerollo et al, 2016) . This may provide a common framework for understanding 410 the role of dopamine in perceptual, cognitive and motor function. 
